Session 66 - 12th CROI

Home

Session 66 Poster Abstracts
Pathogenesis: Determinants and Cellular Factors
Thursday, 1:30 - 3:30 pm
Hall D

329	C-C Chemokine CCL2 Is Differentially Regulated in HIV-1-Infected Individuals Abdul Ansari*, H Heiken, and R Schmidt Hannover Med Sch, Germany
330	Higher Replicative Capacity of Human Immunodeficiency Virus Type 1 Circulating Recombinant Form over Its Parental Subtypes: Implications for Predominance of CRF02_AG in West and West Central Africa Harr F Njai*¹, K Arien¹, C Clybergh¹, Y Gali¹, L Kestens¹, E Arts², M Peeters^3,4, and G Vanham¹ ¹Inst of Tropical Med, Antwerp, Belgium; ²Case Western Reserve Univ, Cleveland, OH, USA; ³Inst de Recherche pour le Dévt, UR 36, Montpellier, France ; and ⁴Univ of Montpellier, France
331	Constrained HIV Replication by Inhibiting Cell Proliferation yet Maintaining Cell Activation Andrea Foli*^1,2, A Groff^1,2, L Lova^1,2, L Boveri^1,2, E Sugliano^1,2, J Lisziewicz^1,2, and F Lori^1,2 ¹Res Inst for Genetic and Human Therapy (RIGHT), Washington, DC, USA and ²Policlin San Matteo, Pavia, Italy
332	Whole Blood Interleukin-18 Concentration During Initial HIV Infection is Associated with HIV Suppression and Reduced CXCR4 HIV Co-receptor Expression. L Shapiro¹, Carrie Sailer*¹, C Dinarello¹, S MaWhinney¹, J Forster¹, A Landay², L Al-Harthi², R Schooley¹, and C Benson¹ ¹Univ of Colorado Hlth Sci Ctr, Denver, USA and ²Rush Univ Med Ctr, Chicago, IL, USA
333	Preliminary Evidence of Differences in Plasma Ghrelin Levels in African American Patients with HIV-related Wasting Compared to Seronegative Controls Keith Crawford*¹, J McNeil², K Kumar³, and J Kwagyan⁴ ¹Howard Univ Coll of Med, Washington, DC, USA; ²Howard Univ Coll of Med, Washington, DC, USA; ³Howard Univ Sch of Pharmacy, Washington, DC, USA; and ⁴Howard Univ Coll of Med, Washington, DC, USA
334	Mucosal Gene Expression Profiles and CD4⁺T-cell Percentages Are Characteristic of the Clinical Outcome in Long-term HIV-infected Non-progressors and Chronically HIV-infected patients Sumathi Sankaran*^1,4, M Guadalupe^1,4, E Reay^1,4, J Flamm², T Prindiville³, and S Dandekar^1,4 ¹MMI Genomics, Davis, CA, USA; ²Kaiser Permanente, Sacramento, CA, USA; ³Univ of California, Davis, USA; and ⁴Univ of California, Davis, USA
335	Syncytium-Inducing Virus associated with HIV-mediated Intestinal Malabsorption Kevin Michael Rufner*¹, L Lai², C Thorpe^1,3, C Wanke^1,3, and T Knox^1,3 ¹Tufts Univ Sch of Med, Boston, MA, USA; ²Washington Hosp Ctr, Washington, DC, USA; and ³Tufts-New England Med Ctr, Boston, MA, USA
336	CD38CD8 Expression Prospectively Predicts CD4 Decline Independent of Plasma HIV-1 Viral Load, Use of HAART of HIV-1 Resistance Profile Jeffrey Klausner*¹, M Bilezikjian¹, M Krone², M Gesner³, S Forte¹, R Donovan³, and H Sheppard³ ¹San Francisco Dept of Publ Hlth, CA, USA; ²Univ of California, San Francisco, USA; and ³California Dept of Hlth Svcs, Richmond, USA
337	DDIT4: DNA-Damage-Inducible Transcript 4 Inhibits Apoptosis in HIV-1-infected T Cells Jiyi Yin*¹, D Shivers¹, and T Finkel^1,2 ¹Children's Hosp of Philadelphia, PA, USA and ²Univ of Pennsylvania, Philadelphia, USA
338	Regulation of IL-7 Receptor (CD127) on CD8⁺ T Cells by in vitro HIV Infection Agatha Komsic-Vranjkovic*, E Faller, P MacPherson, and J Angel Ottawa Hlth Res Inst, Canada
339	The Selection of HIV-1 during Sexual Transmission: Differences in gp160 Diversity in Male-to-Female vs Female-to-Male Transmission Oliver Laeyendecker*¹, J Gamiel², J Shepard², X Li², D Serwadda³, N Sewankambo³, F Wabwire-Mangen³, F McCutchan⁴, J Toma⁵, W Huang⁵, R Gray², M Wawer⁶, and T Quinn^1,2 ¹NIAID, Baltimore MD, USA; ²Johns Hopkins Univ, Baltimore, MD, USA; ³Makerere Univ, Kampala, Uganda; ⁴US Military HIV Res Program, Henry M Jackson Fndn, Rockville MD, USA; ⁵ViroLogic, Inc, South San Francisco, CA, USA; and ⁶Columbia Univ, New York, NY, USA